Jennifer L. Liras
Pfizer (United States)(US)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Carbohydrate Chemistry and Synthesis, Peptidase Inhibition and Analysis, Drug Transport and Resistance Mechanisms, 3D Printing in Biomedical Research
Most-Cited Works
- → Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction(2006)118 cited
- → Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization(2020)105 cited
- → Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration(2019)98 cited
- → Solid and Solution Phase Organic Syntheses of Oligomeric Thioureas(1996)60 cited
- → Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14(2005)59 cited
- → Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1(2004)57 cited
- → Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections(2009)54 cited
- → Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier(2011)47 cited
- → Potent, selective pyrimidinetrione-based inhibitors of MMP-13(2006)47 cited
- → In Vitro–In Vivo Extrapolation of Key Transporter Activity at the Blood–Brain Barrier(2019)46 cited